If a patient on statin therapy has hepatic disease, what is the recommended approach to statin therapy?

Study for the NCLEX Pharmacology Cardiovascular Drugs Test. Explore multiple choice questions with detailed explanations and hints. Prepare confidently for your NCLEX exam!

Multiple Choice

If a patient on statin therapy has hepatic disease, what is the recommended approach to statin therapy?

Statins are processed by the liver and can cause hepatotoxicity, so the safety of using them hinges on the liver’s condition. When hepatic disease is present, the risk of worsening liver injury and drug-induced hepatitis increases, making statins unlikely to be safely tolerated. Therefore, the best approach is to avoid statin therapy in the setting of hepatic disease. Starting with a high dose would heighten the risk rather than mitigate it, and simply monitoring liver enzymes does not remove the safety concern in active liver disease. Not adjusting treatment overlooks a major safety issue in this scenario.

Statins are processed by the liver and can cause hepatotoxicity, so the safety of using them hinges on the liver’s condition. When hepatic disease is present, the risk of worsening liver injury and drug-induced hepatitis increases, making statins unlikely to be safely tolerated. Therefore, the best approach is to avoid statin therapy in the setting of hepatic disease. Starting with a high dose would heighten the risk rather than mitigate it, and simply monitoring liver enzymes does not remove the safety concern in active liver disease. Not adjusting treatment overlooks a major safety issue in this scenario.

More practice questions